ALLAGIUM

Pharmaceuticals for the treatment of cancer, metabolic diseases, Duchenne muscular dystrophy, Noonan syndrome-associated hypertrophic cardiomyopathies and other rare diseases, namely, fibrotic tissue diseases, dystrophic muscle diseases, and therapeutic preparations for the treatment of cancer, metabolic diseases, Duchenne muscular dystrophy, Noonan syndrome-associated hypertrophic cardiomyopathies and other rare diseases, namely, fibrotic tissue diseases, dystrophic muscle diseases